Gene therapy company bluebird bio reports positive test results for treatment
Date Published:
RESEARCH TRIANGLE PARK – bluebird bio, a global gene therapy company with a new manufacturing facility in Durham, has unveiled…
Life Sciences
Triangle therapeutics startup’s deal with global firm RTI is important – here’s why
Date Published:
RESEARCH TRIANGLE PARK – A newly established high-powered Research Triangle Park company, APIE Therapeutics, has signed a licensing agreement with …
Durham’s BioCryst lands $44M contract to test anti-viral drug against COVID-19 virus
Date Published:
RESEARCH TRIANGLE PARK — BioCryst Pharmaceuticals has landed a $44 million contract to see if its investigational anti-viral drug, galidesivir,…
Bill Gates, Alzheimer’s Association provide $740K grant to RTP startup
Date Published:
RESEARCH TRIANGLE PARK – T3D Therapeutics, a life science startup seeking to develop a treatment for Alzheimer’s disease, has another…
RTP-based APIE Therapeutics, RTI team up to develop drug for rare lung disease
Date Published:
RESEARCH TRIANGLE PARK — RTI International is teaming up with a local biopharma startup to develop a treatment for a…
As FDA authorizes plasma to combat COVID-19, Clayton plant working on possible treatment
Date Published:
CLAYTON – President Donald Trump announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called…
Durham life science startup IMMvention shines in LaunchBio Big Pitch competition
Date Published:
RESEARCH TRIANGLE PARK – IMMvention Therapeutix almost hit The Big Pitch out of the park.
Almost.
The 4-year-old Durham company,…
Three NC life science execs crack PharmaVoice ‘most inspiring’ list
Date Published:
RESEARCH TRIANGLE PARK – Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the…
Triangle’s G1 Therapeutics reaches key milestone in fight against cancer
Date Published:
RESEARCH TRIANGLE PARK – G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory…